136 related articles for article (PubMed ID: 35449369)
1. Effect of paracentesis on the survival of patients with terminal cancer and ascites: a propensity score-weighted analysis of the East Asian Collaborative Cross-cultural Study to Elucidate the Dying Process.
Masuda K; Ishiki H; Yokomichi N; Yamaguchi T; Ito T; Takatsu H; Amano K; Hiramoto S; Yamauchi T; Kawaguchi T; Mori M; Matsuda Y; Yamaguchi T
Support Care Cancer; 2022 Jul; 30(7):6233-6241. PubMed ID: 35449369
[TBL] [Abstract][Full Text] [Related]
2. Optimal Paracentesis Volume for Terminally Ill Cancer Patients With Ascites.
Ito T; Yokomichi N; Ishiki H; Kawaguchi T; Masuda K; Tsukuura H; Funaki H; Suzuki K; Oya K; Nakagawa J; Mori M; Yamaguchi T
J Pain Symptom Manage; 2021 Nov; 62(5):968-977. PubMed ID: 33933616
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Procedures for Malignant Ascites in a Palliative Care Outpatient Clinic.
Korpi S; Salminen VV; Piili RP; Paunu N; Luukkaala T; Lehto JT
J Palliat Med; 2018 Jun; 21(6):836-841. PubMed ID: 29489450
[TBL] [Abstract][Full Text] [Related]
4. Is Low Volume Drainage of Ascites Associated With Improved Survival in Digestive System Cancer Patients With Malignant Ascites?-A Retrospective Cohort Study.
Hoshino S; Takagi Y; Fukagawa T; Sano K; Seki N; Hashiguchi Y; Aruga E
J Palliat Care; 2023 Oct; 38(4):473-480. PubMed ID: 37093798
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites.
Colombo N; Mangili G; Mammoliti S; Kalling M; Tholander B; Sternas L; Buzenet G; Chamberlain D
Gynecol Oncol; 2012 Apr; 125(1):42-7. PubMed ID: 22112608
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
[TBL] [Abstract][Full Text] [Related]
8. Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.
Gu X; Zhang Y; Cheng M; Liu M; Zhang Z; Cheng W
BMC Palliat Care; 2016 Apr; 15():44. PubMed ID: 27103467
[TBL] [Abstract][Full Text] [Related]
9. Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.
Wimberger P; Gilet H; Gonschior AK; Heiss MM; Moehler M; Oskay-Oezcelik G; Al-Batran SE; Schmalfeldt B; Schmittel A; Schulze E; Parsons SL
Ann Oncol; 2012 Aug; 23(8):1979-1985. PubMed ID: 22734013
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
11. Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: A case series.
Macken L; Joshi D; Messenger J; Austin M; Tibble J; Mason L; Verma S
Palliat Med; 2017 Jul; 31(7):671-675. PubMed ID: 27707955
[TBL] [Abstract][Full Text] [Related]
12. Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study.
Seah DS; Wilcock A; Chang S; Sousa MS; Sinnarajah A; Teoh CO; Allan S; Chye R; Doogue M; Hunt J; Agar M; Currow DC
Palliat Med; 2022 Oct; 36(9):1408-1417. PubMed ID: 36113139
[TBL] [Abstract][Full Text] [Related]
13. Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England.
Hudson B; Round J; Georgeson B; Pring A; Forbes K; McCune CA; Verne J
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):95-103. PubMed ID: 29150405
[TBL] [Abstract][Full Text] [Related]
14. Malignant ascites symptom cluster in patients referred for paracentesis.
Husain A; Bezjak A; Easson A
Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancer.
Shoji T; Takatori E; Miura Y; Takada A; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Sugiyama T
Int J Gynecol Cancer; 2014 Jul; 24(6):1093-7. PubMed ID: 24978712
[TBL] [Abstract][Full Text] [Related]
16. Effect of continuous deep sedation on survival in patients with advanced cancer (J-Proval): a propensity score-weighted analysis of a prospective cohort study.
Maeda I; Morita T; Yamaguchi T; Inoue S; Ikenaga M; Matsumoto Y; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Tei Y; Kikuchi A; Baba M; Kinoshita H
Lancet Oncol; 2016 Jan; 17(1):115-22. PubMed ID: 26610854
[TBL] [Abstract][Full Text] [Related]
17. Repeat Large-Volume Paracentesis Versus Tunneled Peritoneal Catheter Placement for Malignant Ascites: A Cost-Minimization Study.
Bohn KA; Ray CE
AJR Am J Roentgenol; 2015 Nov; 205(5):1126-34. PubMed ID: 26496562
[TBL] [Abstract][Full Text] [Related]
18. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
[TBL] [Abstract][Full Text] [Related]
19. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
Gaetano JN; Micic D; Aronsohn A; Reddy G; Te H; Reau NS; Jensen D
J Gastroenterol Hepatol; 2016 May; 31(5):1025-30. PubMed ID: 26642977
[TBL] [Abstract][Full Text] [Related]
20. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
